| Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports R Noseda, R Bertoli, L Müller, A Ceschi Journal for immunotherapy of cancer 7, 1-6, 2019 | 66 | 2019 |
| Examining the relationship between internship experiences, teaching enthusiasm, and teacher self-efficacy when using a mobile portfolio app K Michos, A Cantieni, R Schmid, L Müller, D Petko Teaching and Teacher Education 109, 103570, 2022 | 45 | 2022 |
| Seizures as a complication of recreational drug use: Analysis of the Euro-DEN Plus data-set CE Wolfe, DM Wood, A Dines, BP Whatley, C Yates, F Heyerdahl, ... Neurotoxicology 73, 183-187, 2019 | 44 | 2019 |
| Metapholio: A mobile app for supporting collaborative note taking and reflection in teacher education D Petko, R Schmid, L Müller, M Hielscher Technology, Knowledge and Learning 24, 699-710, 2019 | 31 | 2019 |
| Emergency department presentations related to acute toxicity following recreational use of cannabis products in Switzerland Y Schmid, I Scholz, L Mueller, AK Exadaktylos, A Ceschi, ME Liechti, ... Drug and alcohol dependence 206, 107726, 2020 | 29 | 2020 |
| Immune Checkpoint Inhibitors and Pregnancy: Analysis of the VigiBase® Spontaneous Reporting System R Noseda, L Müller, F Bedussi, M Fusaroli, E Raschi, A Ceschi Cancers 15 (1), 173, 2022 | 6 | 2022 |
| Off‐label use of quetiapine in nursing homes: Does medical specialty of prescribing physicians play a role? L Müller, R Noseda, R Bertoli, M Bissig, A Ceschi British journal of clinical pharmacology 86 (7), 1444, 2020 | 6 | 2020 |
| A multidimensional framework for rating health system performance and sustainability: A nine plus one ranking system L Müller, R El Oakley, M Saad, AH Mokdad, GA Etolhi, A Flahault Journal of Global Health 11, 2021 | 5 | 2021 |
| Grippenet: a new tool for the monitoring, risk-factor and vaccination coverage analysis of influenza-like illness in Switzerland A Richard, L Müller, A Wisniak, A Thiabaud, T Merle, D Dietrich, D Paolotti, ... Vaccines 8 (3), 343, 2020 | 4 | 2020 |
| Patient events in German urology: trend towards hybrid formats? P Karschuck, L Müller, C Groeben, C Aksoy, L Flegar, A Zacharis, ... Urologie (Heidelberg, Germany) 63 (1), 75-82, 2023 | 2 | 2023 |
| Technology acceptance of a mobile portfolio app for teacher education: Pre-service teachers views on multimedia-based note-taking and mentoring in internships D Petko, A Cantieni, R Schmid, L Müller, M Krannich, K Michos Journal of Digital learning in teacher eDucation 39 (1), 57-71, 2023 | 2 | 2023 |
| Patientenveranstaltungen in der deutschen Urologie: Trend zu Hybridformaten? P Karschuck, L Müller, C Groeben, C Aksoy, L Flegar, A Zacharis, ... Die Urologie 63 (1), 75-82, 2024 | | 2024 |
| Determinants of Admission to Critical Care Following Acute Recreational Drug Toxicity: A Euro-DEN Plus Study R Noseda, M Franchi, A Pagnamenta, L Müller, AM Dines, I Giraudon, ... Journal of Clinical Medicine 12 (18), 5970, 2023 | | 2023 |
| Versorgungsstruktur der ambulanten Urologie in Deutschland H Haas, L Müller, T Speck, MS Michel, J Huber Die Urologie 62 (5), 503-509, 2023 | | 2023 |
| Structure of outpatient urology care in Germany H Haas, L Müller, T Speck, MS Michel, J Huber Urologie (Heidelberg, Germany) 62 (5), 503-509, 2023 | | 2023 |
| Spikevax booster and delayed urticaria: a Swiss signal with diagnostic uncertainties due to a high proportion of direct patient reports R Noseda, L Müller, T Stammschulte, R Bertoli, A Ceschi European Journal of Clinical Pharmacology 78 (12), 2021-2022, 2022 | | 2022 |
| Immune Checkpoint Inhibitors and Pregnancy: A Pharmacovigilance Analysis in VigiBase® R Noseda, L Mueller, F Bedussi, A Ceschi Drug Safety 45 (10), 1230-1231, 2022 | | 2022 |
| Signal Detection by Disproportionality Analysis in the Monitoring of COVID-19 Vaccine Safety in Switzerland R Noseda, S Ghidossi, L Mueller, R Bertoli, T Stammschulte, A Ceschi Drug Safety 45 (10), 1233-1234, 2022 | | 2022 |
| Spontaneous Reports of Delayed Urticaria Following Booster Vaccination with Spikevax® in Switzerland R Noseda, L Müller, T Stammschulte, R Bertoli, A Ceschi Drug Safety 45 (10), 1233-1233, 2022 | | 2022 |
| Immune Checkpoint Inhibitors and Pregnancy: Analysis of the VigiBase® Spontaneous Reporting System. Cancers 2023, 15, 173 R Noseda, L Müller, F Bedussi, M Fusaroli, E Raschi, A Ceschi | | 2022 |
